BMI-Driven Tolerability and Efficacy of Entresto in Heart Failure Patients

Patient Reported Outcomes inVestigation Following Initiation of Drug Therapy With Entresto (Sacubitril/Valsartan) in Heart Failure

NCT03387163 ·Status: COMPLETED

Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction

NCT02874794 ·Status: COMPLETED ·Phase: PHASE4

Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients

NCT01922089 ·Status: COMPLETED ·Phase: PHASE2

Effect of Sacubitril-Valsartan on Cardiac Structure and Function

NCT06693674 ·Status: RECRUITING ·Phase: PHASE3

Circulating NEP and NEP Inhibition Study in Heart Failure With Preserved Ejection Fraction

NCT03506412 ·Status: COMPLETED ·Phase: PHASE4

Description of Tolerability of LCZ696 (Sacubitril / Valsartan) in Heart Failure With Reduced Ejection Fraction (HFrEF) Treated in Real Life Setting

NCT02690974 ·Status: COMPLETED ·Phase: PHASE4

randOmized stUdy Using acceleromeTry to Compare Sacubitril/valsarTan and Enalapril in Patients With Heart Failure

NCT02900378 ·Status: COMPLETED ·Phase: PHASE3

Real-world Research : Assessment of Effect of Combination of Drugs in the Treatment of Heart Failure

NCT06158711 ·Status: NOT_YET_RECRUITING

Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty

NCT04743063 ·Status: UNKNOWN

Pulmonary REsistance Modification Under Treatment With Sacubitril/valsartaN in paTients With Heart Failure With Reduced Ejection Fraction

NCT05487261 ·Status: RECRUITING ·Phase: PHASE4

EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)

NCT02816736 ·Status: COMPLETED ·Phase: PHASE4

Effects of Sacubitril/Valsartan Therapy on Biomarkers, Myocardial Remodeling and Outcomes.

NCT02887183 ·Status: COMPLETED ·Phase: PHASE4

A Cohort Study to Compare the Hospitalization Between Naive Sacubitril/Valsartan and Naive ACEi/ARBs Heart Failure Patients With Reduced Ejection Fraction Using Secondary US Electronic Health Records Data

NCT05096143 ·Status: COMPLETED

The Effects of Sacubitril/Valsartan Compared to Valsartan on LV Remodelling in Asymptomatic LV Systolic Dysfunction After MI

NCT03552575 ·Status: COMPLETED ·Phase: PHASE3

Effect of Sodium Glucose Cotransporter 2 Inhibitiors on Left Ventricular Remodeling Among Diabetic and Non Diabetic Patients With Chronic Heart Failure

NCT06137430 ·Status: NOT_YET_RECRUITING

Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction

NCT02226120 ·Status: COMPLETED ·Phase: PHASE3

Comparison of BNP and NT-proBNP in the Management of Patients With Chronic and Acute Heart Failure

NCT04107220 ·Status: UNKNOWN ·Phase: NA

This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure

NCT01035255 ·Status: TERMINATED ·Phase: PHASE3

Real World, Pharmacy-assessed Adherence to New Onset Entresto® (Sacubitril/Valsartan) in Patients With Chronic Heart Failure

NCT05870709 ·Status: WITHDRAWN

Study to Evaluate the Effects of Oral Administration of Lixivaptan in Patients With Congestive Heart Failure

NCT01055912 ·Status: COMPLETED ·Phase: PHASE2

Sacubitril-valsartan in Patients With Heart Failure.

NCT07341893 ·Status: COMPLETED ·Phase: NA

" Evaluation of Safety and Efficacy of Empagliflozin and Sacubitril/Valsartan for CHF With Reduced Ejection Fraction in ACHD "

NCT05580510 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Evaluation of the Use of Empagliflozin in Patients with HF with PEF in a Cardiology Outpatient Department

NCT06683053 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Added)

NCT00634309 ·Status: COMPLETED ·Phase: PHASE3

The Bio-Clinical Effects of the (Sacubitril-Valsartan) Combination on Patients With Chronic Heart Failure

NCT04688294 ·Status: COMPLETED ·Phase: PHASE4